2009-11-10 00:27:02 -
GTC Biotherapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com www.companiesandmarkets.com/Summary-Company-Profile/gtc-biothera ..
GTC Biotherapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
GTC Biotherapeutics, Inc. (GTC) is a pharmaceutical company engaged in the development, production, and commercialization of therapeutic proteins through transgenic animal technology. The company is developing a portfolio of recombinant blood proteins to treat an array of genetic and acquired blood deficiencies, including hemophilia and other blood coagulation disorders.
GTCs first product ATryn is a recombinant form of human antithrombin. This product is the first ever transgenically produced protein. It is developing additional recombinant forms of therapeutic proteins normally found in human blood plasma as well as monoclonal antibodies.
The GTC Biotherapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
